e.g. Tata motors, Reliance MF, 500570

Vista Pharmaceuticals Ltd. - Research Center

524711 VISTAPH Group (X) BSE data
 
Back to Company Page
Statement:

Balance sheet

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Sources of funds
Owner's fund
Equity share capital 9.43 7.51 7.36 7.36 6.07
Share application money 4.81 - - - -
Preference share capital - - - - -
Reserves & surplus 26.22 29.20 28.09 25.49 23.57
Loan funds
Secured loans 7.96 9.96 12.55 14.98 15.47
Unsecured loans - - - - -
Total 48.43 46.67 48.00 47.82 45.11
Uses of funds
Fixed assets
Gross block 27.06 26.76 25.74 25.72 25.72
Less : revaluation reserve - - - - -
Less : accumulated depreciation 7.74 7.02 6.41 5.79 5.06
Net block 19.32 19.74 19.33 19.93 20.66
Capital work-in-progress 9.82 9.33 9.08 9.08 8.78
Investments 0.02 0.02 0.03 0.04 0.02
Net current assets
Current assets, loans & advances 28.82 26.95 27.14 21.80 21.66
Less : current liabilities & provisions 9.55 9.36 7.59 3.03 6.01
Total net current assets 19.27 17.58 19.56 18.77 15.65
Miscellaneous expenses not written - - - - -
Total 48.43 46.67 48.00 47.82 45.11
Notes:
Book value of unquoted investments - - 0.03 0.04 0.02
Market value of quoted investments 0.02 0.02 - - -
Contingent liabilities - - - - -
Number of equity sharesoutstanding (Lacs) 471.65 375.57 367.94 367.94 303.65
Close
Add Vista Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Vista Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback